To evaluate the combination of an IAPi/SMACm ± IL-15 superagonist and SIV Env-targeting RhmAbs to reduce the established viral reservoir, we used a macaque model of SIVmac239 infection with ART-mediated suppression of viral replication. This evidence concerns the gene ERVW-1 and infection.